Catalyst Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Ms. Alicia Grande, Catalyst s Current CFO, to Retire at the End of 2023 Dr. Steven Miller Promoted to Executive Vice President, Chief Operating and Scientific Officer and Jeffrey Del Carmen Promoted.
Catalyst Pharmaceuticals (CPRX) Announces Appointment of Michael W Kalb as Chief Financial Officer and Other Executive Promotions streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Operator: Greetings and welcome to the Catalyst Pharmaceuticals first quarter 2023 financial results conference call. At this time, all participants are in a listen-only mode.
Greetings and welcome to the Catalyst Pharmaceuticals First Quarter 2021 Results Conference Call. [Operator Instructions]
It is now my pleasure to introduce your host, Ms. Alicia Grande, Vice President, Chief Financial Officer and Treasurer. Thank you. You may begin.
Alicia Grande
Vice President, Chief Financial Officer and Treasurer
Good morning, everyone, and thank you for joining our conference call to discuss Catalyst s first quarter 2021 financial results and corporate highlights. Leading the call today, we have Patrick McEnany, Chairman and Chief Executive Officer. We are joined by Dr. Steven Miller, Chief Operating Officer and Chief Scientific Officer, and Jeffrey Del Carmen, Chief Commercial Officer. For the question and for the Q&A session, we also have Dr. Gary Ingenito, Chief Medical and Regulatory Officer.